Trevi Therapeutics logo
Trevi Therapeutics TRVI
$ 13.31 -3.69%

Annual report 2025
added 03-17-2026

report update icon

Trevi Therapeutics Total Current Liabilities 2011-2026 | TRVI

Annual Total Current Liabilities Trevi Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
9.75 M 10.5 M 5.82 M 13.4 M 12.7 M 5.56 M 5.2 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
13.4 M 5.2 M 8.99 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
534 M $ 9.13 -0.76 % $ 591 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.59 M $ 0.91 2.42 % $ 6.69 M chinaChina
Edesa Biotech Edesa Biotech
EDSA
1.83 M $ 15.52 -2.39 % $ 49.6 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
395 M $ 22.47 1.19 % $ 3.72 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
49.7 M $ 2.24 0.9 % $ 62.5 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
8.03 M $ 2.26 0.22 % $ 144 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
252 M $ 31.01 -0.13 % $ 1.78 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
ImmuCell Corporation ImmuCell Corporation
ICCC
3.98 M $ 8.44 - $ 76.2 M usaUSA
Incyte Corporation Incyte Corporation
INCY
1.52 B $ 98.87 -0.23 % $ 19.3 B usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
2 M $ 0.71 1.28 % $ 1.74 M canadaCanada
INmune Bio INmune Bio
INMB
8.42 M $ 1.35 1.5 % $ 33.4 M usaUSA
Innoviva Innoviva
INVA
49.7 M $ 23.13 0.35 % $ 1.56 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
11 M - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Jaguar Health Jaguar Health
JAGX
40.7 M $ 7.55 -4.13 % $ 17.6 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
57.4 M $ 26.67 -0.02 % $ 1.44 B britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
37.1 M $ 223.98 -0.39 % $ 4.1 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.22 7.69 % $ 5.3 M israelIsrael
Liquidia Corporation Liquidia Corporation
LQDA
136 M $ 38.39 0.62 % $ 3.3 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aquestive Therapeutics Aquestive Therapeutics
AQST
47.6 M $ 4.08 0.74 % $ 436 M usaUSA